MYR 0.61
(0.83%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 22.53 Million MYR | 14.03% |
2022 | 59.74 Million MYR | 20.05% |
2021 | 49.76 Million MYR | 41.89% |
2020 | 35.07 Million MYR | 804.44% |
2019 | 3.87 Million MYR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 17.43 Million MYR | -11.69% |
2024 Q2 | 18.78 Million MYR | -58.73% |
2023 Q3 | 16.88 Million MYR | 4.71% |
2023 FY | 68.12 Million MYR | 14.03% |
2023 Q2 | 16.12 Million MYR | 4.07% |
2023 Q1 | 15.49 Million MYR | 217.98% |
2023 Q4 | 19.74 Million MYR | 16.96% |
2022 Q3 | 5.21 Million MYR | 0.0% |
2022 FY | 59.74 Million MYR | 20.05% |
2022 Q4 | 4.87 Million MYR | -6.49% |
2021 FY | 49.76 Million MYR | 41.89% |
2020 FY | 35.07 Million MYR | 804.44% |
2019 FY | 3.87 Million MYR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Artroniq Berhad | 11.39 Million MYR | -97.797% |
QES Group Berhad | 34.17 Million MYR | 34.052% |
Pharmaniaga Berhad | 307.82 Million MYR | 92.678% |
Apex Healthcare Berhad | 127.35 Million MYR | 82.302% |